SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,692.16 809.34
(1.66%)

Dow Jones

7,235.98 79.03
(1.10%)

Hang Seng

59,153.23 -764.23
(-1.28%)

Nikkei 225

10,371.76 158.65
(1.55%)

Forex

USD-INR

94.79 0.27
(0.29%)

EUR-INR

110.85 0.20
(0.18%)

GBP-INR

127.93 0.23
(0.18%)

JPY-INR

0.59 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jagsonpal Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

507789

INE048B01035

41.1396078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JAGSNPHARM

31.62

1411.94

EPS(TTM)

Face Value()

Div & Yield %

6.65

1.9

Back

blue pearl agriventures ltd

EPL consolidated net profit declines 12.62% in the December 2025 quarter

Feb 14,2026

Net profit of EPL declined 12.62% to Rs 81.70 crore in the quarter ended December 2025 as against Rs 93.50 crore during the previous quarter ended December 2024. Sales rose 13.26% to Rs 1148.80 crore in the quarter ended December 2025 as against Rs 1014.30 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1148.80	1014.30	13
OPM %	20.01	19.87	-
PBDT	215.60	186.80	15
PBT	118.80	100.50	18
NP	81.70	93.50	-13

76,913.50 -582.86 ( -0.75%)

49,692.16 809.34 (1.66%)

7,235.98 79.03 (1.10%)

59,153.23 -764.23 (-1.28%)

10,371.76 158.65 (1.55%)

94.79 0.27 (0.29%)

110.85 0.20 (0.18%)

127.93 0.23 (0.18%)

0.59 0.00 (-0.01%)